BB's Stock Haven

[beano23]

Always made a killing... here you go.

Bakken Investors Group - pre-newsletter release.

Ticker: SNGX

Price: .28
Target: 3.00+
Initiate: Strong Buy

Due to recent developments we have initiated coverage on Soligenix, Inc. Rated a strong buy we have a 6-9 month price target on SNGX of 3.00 with a much higher target anticipated (updates coming) dependant upon the recent Ricin news and coming implications. The initial news related source can be found here.

http://www.msnbc.msn.com/id/44128981/ns/world_news-the_new_york_times/

*** Soligenix is the world leader in the ricin toxin research and has received more than 20MM in grants in the development of RiVax. With the threat level high we anticipate a fast track and continued grant support to rush this to market.

Numerous analysts have come out with targets of 1.50+ but it is the view or BIG that they are under on the estimates of the upcoming OrBec launch and havn't taken into account the recent Ricin scare.

We are initiating our coverage at a strong buy with more coverage to follow.

Some recent analyst coverage can be found at.

http://www.griffinsecurities.com/pdf/company-reports/Griffin_SNGX_Research_Report_Update_12Jul11.pdf

Also a nice summary of pipeline products and research can be viewed at....

http://investorshub.advfn.com/boards/board.aspx?board_id=5949

Our newsletter and completed broker release will occur on Wednesday, August 17th.